Valeant Patient Assistance Program
The Valeant Patient Assistance Program is a valuable service to help you access the medications you need by providing free or low-cost prescriptions for your Valeant products. Calling the Valeant Patient Assistance toll-free number, may provide you with:
- Information to help you learn how your medications will be reimbursed or covered by your health insurance
- Agents will uncover barriers to coverage, and what steps will be needed to overcome them
- Forms or instructions necessary for your coverage will be faxed or sent directly to your doctor’s office
- Help on how to locate any insurance – including coverage you may not know you have or an older plan you may not know is still active
- Help in getting Valeant medications free of charge for patients who qualify, which requires that you:
- Are a legal resident of the US
- Do not have any known prescription drug coverage
Household Income for Eligible Patients*
If you have any questions about the coverage of TIMOPTIC® in OCUDOSE® by your insurance plan, please call the toll-free hotline on 866-268-7325, Monday – Friday 9am–5pm (except holidays), to request forms or to speak to a knowledgeable Valeant representative.
INDICATIONS AND USAGE
Preservative-free TIMOPTIC® in OCUDOSE® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free TIMOPTIC® in OCUDOSE® may be used when a patient is sensitive to the preservative in Timoptic (timolol maleate ophthalmic solution), benzalkonium chloride, or when use of a preservative-free topical medication is advisable.
IMPORTANT SAFETY INFORMATION
Timoptic is contraindicated in patients with: bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; overt cardiac failure; cardiogenic shock; hypersensitivity to any component of this product.
This drug is absorbed systemically. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. Severe respiratory or cardiac reactions, including death, have been reported following systemic or ophthalmic administration of timolol maleate. Timoptic should be used with caution in patients with cerebrovascular insufficiency.
The most frequently reported adverse experiences have been burning and stinging upon instillation.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
